Jan Scicinski

USPTO Granted Patents = 12 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 108(Granted Patents)

Company Filing History:

Alliant Techsystems Inc.

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357607 - Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (2025-07-15),

2. 11701351 - Treatment of gliomas using organonitro compound combination therapy (2023-07-18),

3. 11660286 - Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products (2023-05-30),

4. 11576895 - Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (2023-02-14),

5. 11160784 - Treatment of brain metastases using organonitro compound combination therapy (2021-11-02),

6. 11008287 - Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine (2021-05-18),

7. 10543208 - Treatment of gliomas using organonitro compound combination therapy (2020-01-28),

8. 10342778 - Treatment of brain metastases using organonitro compound combination therapy (2019-07-09),

9. 9987270 - Treatment of gliomas using organonitro compound combination therapy (2018-06-05),

10. 9468625 - Organonitro thioether compounds and medical uses thereof (2016-10-18),

11. 9139519 - Organonitro thioether compounds and medical uses thereof (2015-09-22),

12. 8664247 - Acyclic organonitro compounds for use in treating cancer (2014-03-04),

Title: Jan Scicinski: Innovator in Medical Therapeutics

Introduction

Jan Scicinski is a prominent inventor based in Saratoga, CA, known for her significant contributions to medical therapeutics. With a total of 12 patents to her name, she has made remarkable advancements in the field of intravenous administration and cancer treatment.

Latest Patents

One of her latest patents is titled "Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone." This invention provides compositions and methods for the intravenous administration of ABDNAZ, including formulations that can be rapidly administered to patients with minimal pain at the infusion site. Another notable patent is "Treatment of gliomas using organonitro compound combination therapy." This invention outlines therapeutic methods and kits for treating gliomas using a specific dosing regimen of ABDNAZ, combined with radiation therapy and other drugs such as temozolomide, irinotecan, or bevacizumab.

Career Highlights

Throughout her career, Jan has worked with several companies, including Epicentrx, Inc. and Radiorx, Inc. Her work has focused on developing innovative solutions for complex medical challenges, particularly in oncology.

Collaborations

Jan has collaborated with notable professionals in her field, including Bryan T. Oronsky and Scott Caroen. These collaborations have further enhanced her research and development efforts.

Conclusion

Jan Scicinski's contributions to medical therapeutics through her patents and collaborations highlight her role as an influential inventor in the healthcare industry. Her work continues to pave the way for advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.